Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Intensified Tyrosine Kinase Inhibitor Therapy (Dasatinib NSC# 732517) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALL)
Status: Enrolling
Updated:  3/25/2016
Seattle Children's Hospital
mi
from
Seattle, WA
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Intensified Tyrosine Kinase Inhibitor Therapy (Dasatinib NSC# 732517) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALL)
Status: Enrolling
Updated: 3/25/2016
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Intensified Tyrosine Kinase Inhibitor Therapy (Dasatinib NSC# 732517) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALL)
Status: Enrolling
Updated:  3/25/2016
Providence Sacred Heart Medical Center & Children's Hospital
mi
from
Spokane, WA
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Intensified Tyrosine Kinase Inhibitor Therapy (Dasatinib NSC# 732517) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALL)
Status: Enrolling
Updated: 3/25/2016
Providence Sacred Heart Medical Center & Children's Hospital
mi
from
Spokane, WA
Click here to add this to my saved trials
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Intensified Tyrosine Kinase Inhibitor Therapy (Dasatinib NSC# 732517) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALL)
Status: Enrolling
Updated:  3/25/2016
West Virginia University Charleston
mi
from
Charleston, WV
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Intensified Tyrosine Kinase Inhibitor Therapy (Dasatinib NSC# 732517) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALL)
Status: Enrolling
Updated: 3/25/2016
West Virginia University Charleston
mi
from
Charleston, WV
Click here to add this to my saved trials
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Intensified Tyrosine Kinase Inhibitor Therapy (Dasatinib NSC# 732517) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALL)
Status: Enrolling
Updated:  3/25/2016
Saint Vincent Hospital
mi
from
Green Bay, WI
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Intensified Tyrosine Kinase Inhibitor Therapy (Dasatinib NSC# 732517) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALL)
Status: Enrolling
Updated: 3/25/2016
Saint Vincent Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Intensified Tyrosine Kinase Inhibitor Therapy (Dasatinib NSC# 732517) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALL)
Status: Enrolling
Updated:  3/25/2016
Marshfield Clinic
mi
from
Marshfield, WI
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Intensified Tyrosine Kinase Inhibitor Therapy (Dasatinib NSC# 732517) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALL)
Status: Enrolling
Updated: 3/25/2016
Marshfield Clinic
mi
from
Marshfield, WI
Click here to add this to my saved trials
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Intensified Tyrosine Kinase Inhibitor Therapy (Dasatinib NSC# 732517) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALL)
Status: Enrolling
Updated:  3/25/2016
Midwest Children's Cancer Center
mi
from
Milwaukee, WI
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Intensified Tyrosine Kinase Inhibitor Therapy (Dasatinib NSC# 732517) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALL)
Status: Enrolling
Updated: 3/25/2016
Midwest Children's Cancer Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Intensified Tyrosine Kinase Inhibitor Therapy (Dasatinib NSC# 732517) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALL)
Status: Enrolling
Updated:  3/25/2016
Royal Brisbane and Women's Hospital
mi
from
Herston,
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Intensified Tyrosine Kinase Inhibitor Therapy (Dasatinib NSC# 732517) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALL)
Status: Enrolling
Updated: 3/25/2016
Royal Brisbane and Women's Hospital
mi
from
Herston,
Click here to add this to my saved trials
Safety and Efficacy of Single Therapy Versus Double and Triple Therapy of the Pellevé™ Wrinkle Treatment System for the Treatment of Moderate Facial Wrinkles
A Prospective, Randomized, Open-Label, 3-Arm Parallel Study Comparing the Safety and Efficacy of Single Therapy Versus Double and Triple Therapy Using the Surgitron® Dual RF™ S5 With the Pellevé™ Wrinkle Treatment Handpiece and Pellevé™ Treatment Gel for the Treatment of Moderate Facial Wrinkles in Fitzpatrick Skin Types I - IV
Status: Enrolling
Updated:  3/28/2016
DeNova Research Institute
mi
from
Chichago, IL
Safety and Efficacy of Single Therapy Versus Double and Triple Therapy of the Pellevé™ Wrinkle Treatment System for the Treatment of Moderate Facial Wrinkles
A Prospective, Randomized, Open-Label, 3-Arm Parallel Study Comparing the Safety and Efficacy of Single Therapy Versus Double and Triple Therapy Using the Surgitron® Dual RF™ S5 With the Pellevé™ Wrinkle Treatment Handpiece and Pellevé™ Treatment Gel for the Treatment of Moderate Facial Wrinkles in Fitzpatrick Skin Types I - IV
Status: Enrolling
Updated: 3/28/2016
DeNova Research Institute
mi
from
Chichago, IL
Click here to add this to my saved trials
The Effect of Selenium Supplementation Among Pediatric Patients With Burns
The Effect of Selenium Supplementation Among Pediatric Patients With Burns
Status: Enrolling
Updated:  3/31/2016
Shriners Hospitals for Children
mi
from
Boston, MA
The Effect of Selenium Supplementation Among Pediatric Patients With Burns
The Effect of Selenium Supplementation Among Pediatric Patients With Burns
Status: Enrolling
Updated: 3/31/2016
Shriners Hospitals for Children
mi
from
Boston, MA
Click here to add this to my saved trials
Nitric Oxide Production in MELAS Syndrome
Arginine Flux and Nitric Oxide Production in Patients With MELAS Syndrome and the Effect of Arginine and Citrulline Supplementation
Status: Enrolling
Updated:  4/1/2016
Texas Children's Hospital
mi
from
Houston, TX
Nitric Oxide Production in MELAS Syndrome
Arginine Flux and Nitric Oxide Production in Patients With MELAS Syndrome and the Effect of Arginine and Citrulline Supplementation
Status: Enrolling
Updated: 4/1/2016
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Cooling Lower Leg Skin to Prevent Venous Leg Ulcers in Patients With Poor Vein Circulation
Preventing Venous Leg Ulcers With Cryotherapy: A Randomized Clinical Trial
Status: Enrolling
Updated:  4/3/2016
Medical University of South Carolina
mi
from
Charleston, SC
Cooling Lower Leg Skin to Prevent Venous Leg Ulcers in Patients With Poor Vein Circulation
Preventing Venous Leg Ulcers With Cryotherapy: A Randomized Clinical Trial
Status: Enrolling
Updated: 4/3/2016
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Cooling Lower Leg Skin to Prevent Venous Leg Ulcers in Patients With Poor Vein Circulation
Preventing Venous Leg Ulcers With Cryotherapy: A Randomized Clinical Trial
Status: Enrolling
Updated:  4/3/2016
Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Cooling Lower Leg Skin to Prevent Venous Leg Ulcers in Patients With Poor Vein Circulation
Preventing Venous Leg Ulcers With Cryotherapy: A Randomized Clinical Trial
Status: Enrolling
Updated: 4/3/2016
Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Auricular Acupuncture for The Treatment of Post-Tonsillectomy Pain
Auricular Acupuncture for The Treatment of Post-Tonsillectomy Pain
Status: Enrolling
Updated:  4/5/2016
NMCSD Balboa
mi
from
San Diego, CA
Auricular Acupuncture for The Treatment of Post-Tonsillectomy Pain
Auricular Acupuncture for The Treatment of Post-Tonsillectomy Pain
Status: Enrolling
Updated: 4/5/2016
NMCSD Balboa
mi
from
San Diego, CA
Click here to add this to my saved trials
Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery
Trial of Directed High-dose Nasal Steroids on Residual Olfactory Dysfunction in Patients With Chronic Rhinosinusitis Following Endoscopic Sinus Surgery
Status: Enrolling
Updated:  4/5/2016
UNC Chapel Hill Department of Otolaryngology/Head and Neck Surgery
mi
from
Chapel Hill, NC
Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery
Trial of Directed High-dose Nasal Steroids on Residual Olfactory Dysfunction in Patients With Chronic Rhinosinusitis Following Endoscopic Sinus Surgery
Status: Enrolling
Updated: 4/5/2016
UNC Chapel Hill Department of Otolaryngology/Head and Neck Surgery
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Applying the Use of Motivational Tools to Auditory Rehabilitation
Applying the Use of Motivational Tools to Auditory Rehabilitation
Status: Enrolling
Updated:  4/8/2016
VA Portland Health Care System, Portland, OR
mi
from
Portland, OR
Applying the Use of Motivational Tools to Auditory Rehabilitation
Applying the Use of Motivational Tools to Auditory Rehabilitation
Status: Enrolling
Updated: 4/8/2016
VA Portland Health Care System, Portland, OR
mi
from
Portland, OR
Click here to add this to my saved trials
Risk Education and Assessment for Cancer Heredity
Bridging Geographic Barriers: Remote Cancer Genetic Counseling for Rural Women
Status: Enrolling
Updated:  4/12/2016
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Risk Education and Assessment for Cancer Heredity
Bridging Geographic Barriers: Remote Cancer Genetic Counseling for Rural Women
Status: Enrolling
Updated: 4/12/2016
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
Phase I Study of Belinostat (PXD-101) and Velcade (Bortezomib) in Relapsed or Refractory Acute Leukemia/ Myelodysplastic Syndrome
Status: Enrolling
Updated:  4/13/2016
Virginia Commonwealth University
mi
from
Richmond, VA
Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
Phase I Study of Belinostat (PXD-101) and Velcade (Bortezomib) in Relapsed or Refractory Acute Leukemia/ Myelodysplastic Syndrome
Status: Enrolling
Updated: 4/13/2016
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
Phase I Study of Belinostat (PXD-101) and Velcade (Bortezomib) in Relapsed or Refractory Acute Leukemia/ Myelodysplastic Syndrome
Status: Enrolling
Updated:  4/13/2016
M D Anderson Cancer Center
mi
from
Houston, TX
Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
Phase I Study of Belinostat (PXD-101) and Velcade (Bortezomib) in Relapsed or Refractory Acute Leukemia/ Myelodysplastic Syndrome
Status: Enrolling
Updated: 4/13/2016
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
Characterization of Potential Biomarkers to Assess Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
Status: Enrolling
Updated:  4/14/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
Characterization of Potential Biomarkers to Assess Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
Status: Enrolling
Updated: 4/14/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Electroacupuncture in Treating Chronic Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer
Electroacupuncture for Xerostomia in Head and Neck Patients
Status: Enrolling
Updated:  4/18/2016
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Electroacupuncture in Treating Chronic Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer
Electroacupuncture for Xerostomia in Head and Neck Patients
Status: Enrolling
Updated: 4/18/2016
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Complete Healthcare for Women
mi
from
Columbus, OH
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Complete Healthcare for Women
mi
from
Columbus, OH
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Hawaii Pacific Health
mi
from
Honolulu, HI
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Hawaii Pacific Health
mi
from
Honolulu, HI
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Jersey Shore University Medical Center
mi
from
Neptune, NJ
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Jersey Shore University Medical Center
mi
from
Neptune, NJ
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Long Beach Memorial Medical Center
mi
from
Long Beach, CA
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Long Beach Memorial Medical Center
mi
from
Long Beach, CA
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Norton Healthcare
mi
from
Louisville, KY
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Norton Healthcare
mi
from
Louisville, KY
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Obstetrix Medical Group of California
mi
from
Campbell, CA
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Obstetrix Medical Group of California
mi
from
Campbell, CA
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Obstetrix Medical Group of Washington, Inc
mi
from
Seattle, WA
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Obstetrix Medical Group of Washington, Inc
mi
from
Seattle, WA
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Regional Obstetrical Consultants
mi
from
Chatanooga, TN
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Regional Obstetrical Consultants
mi
from
Chatanooga, TN
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Saint Luke's Hospital, Kansas City
mi
from
Kansas City, MO
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Saint Luke's Hospital, Kansas City
mi
from
Kansas City, MO
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Saint Peter's Hospital
mi
from
New Brunswick, NJ
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Saint Peter's Hospital
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
San Gabriel Valley Perinatal Medical Center
mi
from
Monterey Park, CA
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
San Gabriel Valley Perinatal Medical Center
mi
from
Monterey Park, CA
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Scripps Clinic Carmel Valley
mi
from
San Diego, CA
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Scripps Clinic Carmel Valley
mi
from
San Diego, CA
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
South Florida Perinatal
mi
from
Miami, FL
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
South Florida Perinatal
mi
from
Miami, FL
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Southeast Perinatal Associates - Miramar
mi
from
Miramar, FL
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Southeast Perinatal Associates - Miramar
mi
from
Miramar, FL
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Southeast Perinatal Associates - Weston
mi
from
Sunrise, FL
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Southeast Perinatal Associates - Weston
mi
from
Sunrise, FL
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
University of Cincinnati
mi
from
Cincinnati, OH
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
University of Iowa Health Care
mi
from
Iowa City, IA
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
University of Iowa Health Care
mi
from
Iowa City, IA
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
University of Maryland
mi
from
Baltimore, MD
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
University of South Alabama
mi
from
Mobile, AL
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
University of South Alabama
mi
from
Mobile, AL
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Virtua Health
mi
from
Sewell, NJ
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Virtua Health
mi
from
Sewell, NJ
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Virtua Health
mi
from
Voorhees, NJ
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Virtua Health
mi
from
Voorhees, NJ
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Visions Clinical Research Tuscon
mi
from
Tucson, AZ
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Visions Clinical Research Tuscon
mi
from
Tucson, AZ
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Willis-Knighton Physician Network
mi
from
Shreveport, LA
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Willis-Knighton Physician Network
mi
from
Shreveport, LA
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
William Beaumont Hospital
mi
from
Royal Oak, MI
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated:  4/18/2016
North York General Hospital
mi
from
Toronto,
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy
Status: Enrolling
Updated: 4/18/2016
North York General Hospital
mi
from
Toronto,
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
University of South Alabama
mi
from
Mobile, AL
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
University of South Alabama
mi
from
Mobile, AL
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
New Horizon Women's Care
mi
from
Chandler, AZ
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
New Horizon Women's Care
mi
from
Chandler, AZ
Click here to add this to my saved trials